Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000921895-25-000474·89bio, Inc.
Schedule 13G ownership disclosure
N/A
Common Stock, par value $0.001 per share · CUSIP: 282559103
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L P
Shares: 2,227,427.00 · Class: 1.9%
- BVF I GP LLC
Shares: 2,227,427.00 · Class: 1.9%
- BIOTECHNOLOGY VALUE FUND II LP
Shares: 1,799,517.00 · Class: 1.5%
- BVF II GP LLC
Shares: 1,799,517.00 · Class: 1.5%
- Biotechnology Value Trading Fund OS LP
Shares: 223,979.00 · Class: 0.2%
- BVF Partners OS Ltd.
Shares: 223,979.00 · Class: 0.2%
- BVF GP HOLDINGS LLC
Shares: 4,026,944.00 · Class: 3.4%
- BVF PARTNERS L P/IL
Shares: 4,333,885.00 · Class: 3.6%
- BVF INC/IL
Shares: 4,333,885.00 · Class: 3.6%
- LAMPERT MARK N
Shares: 4,333,885.00 · Class: 3.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-000474
- Form type
- SCHEDULE 13G/A
- Filer
- 89bio, Inc.
- CIK
- CIK 1785173
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership